suramin has been researched along with cdw17 antigen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delézay, O; Fantini, J; Hammache, D; Yahi, N | 1 |
Chatterjee, S; Kolmakova, A; Pili, R; Rajesh, M; Zang, D | 1 |
2 other study(ies) available for suramin and cdw17 antigen
Article | Year |
---|---|
SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Topics: Antibodies, Monoclonal; Antigens, CD; Antiviral Agents; Binding Sites; Carbohydrate Sequence; CD4-Positive T-Lymphocytes; Cells, Cultured; Chromatography, Thin Layer; Gangliosides; Glycosphingolipids; HIV Envelope Protein gp120; HIV-1; Humans; Lactosylceramides; Molecular Sequence Data; Peptide Fragments; Recombinant Proteins; Sulfoglycosphingolipids; Suramin | 1996 |
VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo.
Topics: Animals; Antigens, CD; Blotting, Western; Cell Line; Cell Line, Tumor; Chromones; Endothelial Cells; Female; Fibroblast Growth Factor 2; Galactosyltransferases; Glucosyltransferases; Humans; Lactosylceramides; Mice; Mice, Nude; Morpholines; Neovascularization, Physiologic; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Lysosphingolipid; Sphingosine; Suramin; Vascular Endothelial Growth Factor A | 2009 |